First Time Loading...

LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 67.2 USD 1.97% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. [ Read More ]

The intrinsic value of one LMAT stock under the Base Case scenario is 45.6 USD. Compared to the current market price of 67.2 USD, LeMaitre Vascular Inc is Overvalued by 32%.

Key Points:
LMAT Intrinsic Value
Base Case
45.6 USD
Overvaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
LeMaitre Vascular Inc

Backtest LMAT Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling LMAT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of LeMaitre Vascular Inc's business.

What risks and challenges
does LeMaitre Vascular Inc face in the near future?

Summarize the latest earnings report
of LeMaitre Vascular Inc.

Provide P/E
for LeMaitre Vascular Inc and its competitors.

Financials

Balance Sheet Decomposition
LeMaitre Vascular Inc

Current Assets 194.6m
Cash & Short-Term Investments 105.1m
Receivables 25.1m
Other Current Assets 64.5m
Non-Current Assets 152.2m
PP&E 39.8m
Intangibles 107.7m
Other Non-Current Assets 4.7m
Current Liabilities 29.9m
Accounts Payable 3.7m
Accrued Liabilities 25.7m
Other Current Liabilities 414k
Non-Current Liabilities 19m
Other Non-Current Liabilities 19m
Efficiency

Earnings Waterfall
LeMaitre Vascular Inc

Revenue
193.5m USD
Cost of Revenue
-66.4m USD
Gross Profit
127m USD
Operating Expenses
-89.9m USD
Operating Income
37.2m USD
Other Expenses
-7.1m USD
Net Income
30.1m USD

Free Cash Flow Analysis
LeMaitre Vascular Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

LMAT Profitability Score
Profitability Due Diligence

LeMaitre Vascular Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Operating Income
61/100
Profitability
Score

LeMaitre Vascular Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

LMAT Solvency Score
Solvency Due Diligence

LeMaitre Vascular Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

LeMaitre Vascular Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LMAT Price Targets Summary
LeMaitre Vascular Inc

Wall Street analysts forecast LMAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LMAT is 70.51 USD with a low forecast of 54.54 USD and a high forecast of 88.2 USD.

Lowest
Price Target
54.54 USD
19% Downside
Average
Price Target
70.51 USD
5% Upside
Highest
Price Target
88.2 USD
31% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

LMAT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

LMAT Price
LeMaitre Vascular Inc

1M 1M
-5%
6M 6M
+22%
1Y 1Y
+31%
3Y 3Y
+50%
5Y 5Y
+135%
10Y 10Y
+842%
Annual Price Range
67.2
52w Low
45.37
52w High
71.06
Price Metrics
Average Annual Return 13.14%
Standard Deviation of Annual Returns 17.22%
Max Drawdown -45%
Shares Statistics
Market Capitalization 1.5B USD
Shares Outstanding 22 337 200
Percentage of Shares Shorted 4.43%

LMAT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc

Country

United States of America

Industry

Health Care

Market Cap

1.5B USD

Dividend Yield

0.95%

Description

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The company sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The firm sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.

Contact

MASSACHUSETTS
Burlington
63 2nd Ave
+17812212266.0
http://www.lemaitre.com/

IPO

2006-10-19

Employees

450

Officers

Chairman & CEO
Mr. George W. LeMaitre
President & Director
Mr. David B. Roberts
CFO, Treasurer, Secretary & Director
Mr. Joseph P. Pellegrino Jr.
Senior Vice President of Operations
Mr. Trent G. Kamke
Founder and Chairman of Scientific Advisory Board
Dr. George D. LeMaitre
General Counsel
Mr. David C. Hissong
Show More
Vice President of Marketing
Ms. Kimberly L. Cieslak
Director of Human Resources
Mr. Daniel J. Mumford
Senior Vice President of Advanced Manufacturing Engineering
Mr. Ryan H. Connelly
Senior Vice President of Clinical, Regulatory & Quality Affairs
Mr. Andrew Hodgkinson
Show Less

See Also

Discover More
What is the Intrinsic Value of one LMAT stock?

The intrinsic value of one LMAT stock under the Base Case scenario is 45.6 USD.

Is LMAT stock undervalued or overvalued?

Compared to the current market price of 67.2 USD, LeMaitre Vascular Inc is Overvalued by 32%.